4 June 2021

VIVEbiotech launches lentiviral vector manufacturing plant for cell and gene therapy sector

VIVEbiotech’s production capacity will increase by 400%, with an increase in average batch size per year from 20 in 2020 to 80 in 2022.

Read more

27 April 2021

Report about VIVEbiotech in El Confidencial

On the occasion of being a finalist for the 2020 Pyme Award, Banco Santander has made known the great work we do at VIVEbiotech manufacturing lentiviral...

Read more

18 March 2021

VIVEbiotech participates in the “V. Professional Training Forum in biotech companies”

FP/Parke is an initiative that aims to arouse the interest of the youngest in technological professions with the collaboration of leading companies in the...

Read more

26 February 2021

DEFACTO selects VIVEbiotech to include it in its project

The marketing and communication consultancy DEFACTO has selected VIVEbiotech as a chameleon company that has known how to adapt to the COVID-19 crisis.

Read more

26 February 2021

VIVEbiotech finalist of the National SME 2020 Award

VIVEbiotech has been one of the five finalists of the National SME 2020 Award.

Read more

24 February 2021

VIVEbiotech is expanding its manufacturing capabilities with new facilities

VIVEbiotech expands facilities to increase innovation and manufacturing capabilities of specialist lentiviral vectors.

Read more

10 February 2021

Renewal of the CIR Certification from the Government of France

VIVEbiotech obtains the renewal of the CIR Certification from the Ministry of Higher Education, Research and Innovation of the Government of France.

Read more

10 February 2021

Authorization to manufacture investigational medicinal products

VIVEbiotech obtains authorization to manufacture investigational medicinal products.

Read more

8 February 2021

In 2021 we continue to participate in congresses

Successful participation of VIVEbiotech in three international conferences in Q1 2021.

Read more

21 January 2021

Webinar on Cell & Gene Therapy Insights

VIVEbiotech and Polyplus-transfection give a webinar on Cell & Gene Therapy Insights.

Read more